Abstract. A dosimetry intercomparisan has been carried out for all 64 radiotherapy centres in the UK. Doses were measured with an ionization chamber in an epoxy resin watersubstitute phantom of relatively simple geometry. Reference-point measurements were made for all MV photon beams. For 61 CO-60 beams, a mean ratio of measured-to-stated dose of 1.002 was observed with a standard deviation of 0.014, whilst for 100 MV x-ray beams, the corresponding figures were 1.003 and 0.015. 97% of beams lay within a +3% deviation. One measurement was instrumental in discovering a large discrepancy. Doses were also investigated in two planned three-field distributions at one beam quality in each centre. One of these was in a homogeneous phantom, whilst the second included a lung-equivalent insee. Doses were measured at the central point and at four other paints in the high dose volume. In both situations, the mean ratio of measured-to-calculated doses for all points was 1.008, with standard deviations of 0.027 and 0.035 for the uniform and non-uniform phantoms, respectively. Discrepancies over 5% were followed up. The work must be viewed in the context of other international intercomparisons and is an essential part of wider radiotherapy audit processes.
Introduction
Quality assurance and quality control have always been recognized as being important in radiotherapy. However, an increasing emphasis on these aspects has been apparent in recent years (ACR 1984 , WHO 1987 , Brahme e t a / 1988, EORTC 1989, and references therein). The demands on accuracy and consistency in radiotherapy are determined by the steepness and separation of dose-effect curves, for both tumour control and normal tissue complications. Surveys of this information have led to recommendations on required accuracy in clinical dosimetry. ICRU (1976) points to a need for an accuracy of at least +5% in the delivery of an absorbed dose to a target volume in a patient. Other authors have generally supported this. For example, Mijnheer et a / (1987) and Brahme er a / (1988) propose recommended tolerance levels on accuracy in dose delivery of 3.5% and 3% respectively, given as one relative standard deviation. It must be appreciated that these tolerances are on final delivered dose to the patient at the end of all the processes involved in ratiotherapy dosimetry. This dosimetry chain 0031-9155/92/020445+ 17304.50 0 1992 IOP Publishing Ltd begins with primary dosimetry standards and physical data. It leads through dosemeter calibration, treatment beam calibration in reference conditions, relative dosimetry in all other conditions and the treatment planning process, including acquisition of patient data. It ends with the delivery of the prescribed, planned and accepted treatment to the patient under day-to-day conditions over the course of the treatment. A detailed analysis of these steps has been carried out by Johansson'(l982) . The accuracy requirement on each part of the whole process must be significantly less than the overall recommendations to achieve the final values required.
Such demands lead to the need for recommendations on quality assurance programmes for equipment and procedures in radiotherapy. In the UK the IPSM is instrumental in setting standards for dosimetry (HPA 1983 and 1985 , IPSM 1990a and 1991a and quality assurance (HPA 1970 , IPSM 1988 and 1991b . These are aimed at producing consistency in dosimetry between centres. Despite standard protocols, errors may occur due to inexact implementation of protocols, equipment problems or mistakes. Dosimetry intercomparison is a method of quality audit that can reveal errors and can assess consistency between centres. Doses are measured at each centre, using the same equipment and procedures, and compared to the values stated by the centre. Such intercomparisons can be carried out at various levels in the dosimetry chain.
A number of dosimetry intercomparisons have been reported. These can be divided into three categorics:
(i) National laboratories, or centres with particular experience in dosimetry, have compared measurements in order IO compare protocois and doserneirrs (see, for example, Almond et a1 , Johansson 1982 .
(ii) A growing number of intercomparisons have been carried out to assess protocol compliance between centres; making measurements under fixed conditions which either duplicate or approximate to reference conditions. These are essentially assessing consistency of dosimetry at the treatment beam calibration level (Eisenlohr and Jayaraman 1977 1991) . Some are based on mailed dosemeters, generally TLD, having some limitations on precision and implementation. Others are based on visits to each centre with ionization measuring systems, which improves these considerations but requires increased resources.
(iii) Several intercomparisons have been designed to assess uncertainties at other levels of the clinical dosimetry chain. These range from additional measurements in simple non-reference coliditions and 1986 , Wittkamper er a1 1987 , EORTC 1989 to more complex intercomparisons in anatomical phantoms (Worsnop 1968 . Johansson et a1 1987 , Wittkamper et a1 1987 . The latter are attempting to assess uncertainties close to the end of the clinical dosimetry chain, including some of the uncertainties introduced by the acquisition o f patient data and in the treatment planning process. They have not included any other patient problems or day-to-day variations throughout treatment delivery.
Some of these intercomparisons have been carried out as one component of wider continuing quality audits of dosimetry for patients entered into clinical trials. The most extensive of these is the long-running AAPM Radiological Physics Center (RPC) programme (Golden er a1 1972, Hanson et al 1991), funded by the National Cancer Institute (USA). The EORTC programme (Johansson er a1 1986 , EORTC 1989 ) serves a similar function in support of EORTC clinical trials. Reviews of the results of a range of intercomparisons have been presented by Johansson (1987) and
Wittkamper et a/ (1987) . Some general statements can be made: (i) all have shown some clinically significant variations; (ii) standard deviations on the observed distributions increase on going from CO-60 to MV x-rays to electrons and on going from reference-point measurements to more complex situations involving more factors; and (iii) standard deviations and the incidence of major discrepancies decrease in repeated intercomparisons.
No similar comprehensive study has been carried out in the UK, although some UK centres have participated in limited intercomparisons linked to specific clinical trials etc (Barrett cf a / 1990). For this reason, an IPSM Working Party was established with a remit to plan and coordinate the present study. The specific aims of the intercomparison were twofold: (i) To establish the variations of the definitive absorbed dose measurement in reference irradiation conditions in a phanton, and
(ii) to investigate the agreement between relative dose distributions derived by treatment planning systems and the absorbed dose values measured at specific points within these calculated plans.
Two points in the dosimetry chain were to be considered (i) up to and including treatment beam calibration, and (ii) up to and including the physical aspects of planned multi-beam treatments. The approach used was to separate physical aspects from specifically clinical and patient-related aspects of the process. Thus a relatively simple phantom was specified, in terms of shape and set up, with no attempt to simulate any specific clinical situation, but able to test the inclusion of a range of factors. To achieve these aims, a phantom was designed which enabled dose measurements at a reference point to be carried out and three-field treatments to be planned which included an oblique beam incidence and the presence of a lung-equivalent volume. This phantom and the full set of equipment necessary to make the required measurements were used at every UK centre to carry out the intercomparison.
Methods
The phantom used for the study was designed by the IPSM Radiotherapy Topic Group in 1982 and is shown in figure 1. It was made of epoxy-resin water-equivalent material by the Department of Medical Physics at the London Hospital (Klevenhagen el a / 1983). I t had six 3 c m diameter removable water-equivalent rods which could be replaced by an insert which had been machined to accept a Farmer-type ionization chamber. One hole was used for the reference-point measurements and the other five for the planned dose distributions. A 9 cm diameter water-equivalent insert could be replaced by one containing an 8 cm diameter core of lung-equivalent material with an electron density of 0.25 compared with water. Doses were measured using a Nuclear Enterprises 2570 dosemeter with a graphitewalled Farmer chamber (type 2571). The chamber was calibrated against a secondary standard exposure meter (Nuclear Enterprises model 2560/2561) which had been calibrated at the National Physical Laboratory. The HPA Code of Practice (HPA 1983) was used to derive absorbed dose to water. In the analysis of the results it was assumed that it was appropriate to apply the calibration factor for the nominal energy stated by the participating centre. The survey chamber was calibrated at threeenergies (CO-60, 8 MV and 16 MV) at Belvidere Hospital (Glasgow) periodically throughout the duration of the study. Calibration factors at other energies were derived by interpolating the ratio of responses of the secondary standard to those of the Farmer chamber and applying the appropriate CA factor. The maximum variation in the response ratio for the three energies on any calibration date was 0.3%. For energies greater than 16 MV it was assumed that the response ratio for the two chambers was equal to that at 16 MV. In addition to the calibrations, the dosemeter response was checked at approximately monthly intervals using a Sr-90 check source. The readings of the dosemeter were corrected for pressure using a n aneroid barometer (type M2236) made by Negretti Reference-point measurements were made for all megavoltage treatment units at each of the centres visited. Factors were calculated from output and depth-dose charts to give an absorbed dose of 2 Gy to the reference point. The reference point was on the central axis of the beam at a depth of 5 cm. The measured dose at this point was compared with the calculated value. Three field sizes were assessed; 5 x 5 cm2, l o x 10cm2 and 15x 15 cm2. For dual photon energy units, both treatment energies were surveyed. There was an option for centres with two or more identical treatment units to make measurements on only one of those units.
In addition to the reference-point measurements, the doses at five points in two planned-dose distributions were studied for one megavoltage beam in each centre. For the planned distributions, the participants were asked to use a beam in the 6-10 MV energy range. If this was not available, then the highest energy beam below 6 MV was to be used. The water-equivalent insert was used for the first planned distribution and the lung-equivalent for the second. An irradiation was to be planned to give a uniform dose to an 8 x 8 x 8 cm3 volume with three fields as shown in figure 2. This arrangement of fields was to be used in each case but the irradiation could be planned isocentrically or with fixed FSDS, depending on local clinical practice. The participants could choose the field sizes as they considered appropriate. Doses were measured at the central point and at four other points within the high dose volume as shown in figure 2 . The dose to be delivered to the reference point and to the central point of the planned-dose distributions was specified to be 2 Cy and was calculated using the centre's treatment planning system.
The survey was organized through a system of regional coordinators. The radiotherapy centres were grouped into 15 regions with between two and six centres in each region. The coordinator took the equipment to each centre in his region and carried out the series of measurements with a physicist from the local centre. When he had completed the measurements in his own region, the coordinator went to the next coordinator's centre and assisted with measurements at that centre before handing the equipment on. The measured data were returned to one member of the working party for analysis and the results sent to the physicist at the centre concerned. If there was a discrepancy of 5% or more between the measured dose and the calculated dose, either at the reference point for a single field size or at the central point of either planned distribution, the participating centre would be asked to investigate the cause.
Results
The survey was started in January 1987 and completed in January 1991. The intercomparison was carried out at 64 radiotherapy centres in the UK. Of these, 62 were NHS hospitals and two were private. At these centres 161 sets of reference-point measurements were returned as well as full dose distributions for 62 treatment units. During the period of the survey the graphite cap of the chamber was broken once. Before this event the check-source measurements showed a maximum variation of 1.0% for 20 measurements with a standard deviation (sd) of 0.3%. For the 28 check measurements following repair, the maximum variation was 0.9% (sd = 0.2%). The maximum range of the calibration factor measured for any energy over the duration of the intercomparison was 0.4%.
Reference point
Reference-point survey reports were available from 63 of the 64 hospitals which were visited. Detailed data from the other centre were not available for this analysis but will be outlined in section 3.3. Figure 3 shows the distribution of beam energies for the reference-point measurements. Of the 161 surveys 61 were for cobalt-60 units, the next most common energy being 6 MV (27 beams). The maximum number of reference-point studies in any centre was seven with the majority of centres having two or three treatment units (70%). Ten of the centres had a single treatment unit.
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Results are expressed as the ratio of the measured dose to the calculated value (2 Cy). The variation in this ratio for the average of the three field sizes is shown in figure 4 . The average ratio was 1.003 (sd = 0.015) with minimum and maximum values for the measurements at any one field size being 0.960 and 1.066. Analysis of the l o x 10 cm2 field, which is the standard reference field, yields an identical result. The data were analysed to see if there were any systematic differences between CO-60 beams and megavoltage x-rays. The average ratios were 1.002 (sd=0.014) and 1.003 ( s d = 0.015) for the two groups, respectively.
Reference-point measurements were made at three different field sizes on 159 out of the 161 therapy beams. To assess consistency in dosimetry, the ratio of maximum-tominimum measured-to-calculated dose ratio was analysed. These data are presented in figure 5 . For 103 (65%) of the beams the discrepancy was 1% or less. Five beams showed a variation in excess of 3% (maximum 6.6%). Figure 6 shows the variation in Maxjmin rcfcrcncc point doss Figure 6 . Distribution of the range of the average measured-to-calculated dose ratio at the reference point for those centres at which more than one treatment beam was studied.
average dose ratio for the reference-point measurements in the 53 centres in which more than one beam was studied. It can be seen that for 13 centres (25%) there is a measured discrepancy of 3% or more between different beams (maximum 5.8%). A discrepancy greater than 5% was observed for only one of the results which are included in this analysis. In addition a difference of approximately 25% has been reported elsewhere for the centre for which data were not returned for this analysis (Thwaites 1988) . These discrepancies are discussed in section 3.3.
Planned-dose distributions
Doses in the planned-dose distributions were reported from 62 centres. The distribution of beam energies is shown in figure 3 . The most common energies were 6 MV and 8 MV, each used by 18 participants. The protocol precluded beam energies greater than 10 MV, unless this was the only beam available. Of the plans analysed, 51 (84%) were for isocentric treatments. For CO-60 units the proportion of isocentric irradiations was lower ( 5 out of 9; 56%). One of the participants only performed measurements for the central point in the dose distributions. Dose distributions were planned on computer systems by 59 of the 62 participants (the other three using hand planning). Of the computer systems, 11 out of 59 used software which had been developed by the centre and was not commercially available. In the other 48 centres, planning systems from 10 different manufacturers were used, with one manufacturer supplying to 22 (46%) of these centres. Figure 7 shows the average measured-to-calculated dose ratio for the five points in the dose distribution with the water-equivalent insert. The results for the distribution with the lung-equivalent insert are shown in figure 8 . Average values of the measured-tocalculated dose ratio are given in table 1 with their standard deviations and the minimum and maximum values. Also shown are the dose ratios for the central point in the distribution. The ratio of measured-to-calculated dose ratio for the central point to the average of the four peripheral points does not indicate any systematic discrepancies.
To assess the self consistency of the dose distribution and reference-point measurements for the same beam, the distribution of ratios of central point to average referencepoint dose is shown in figure 9 for the measurements with the water-equivalent insert. The average of this ratio is given in table 1 for both dose distributions A test of the consistency between the two planned-dose distributions is to compare the central doses. In table 1 it can be seen that the average ratio is 1.001. Although centres were informed that the relative electron density of the lung-equivalent material was 0.25, 22 of the 58 centres, for which data were available and which did not use hand planning, elected to use higher values in accordance with their normal clinical practice. Table 2 shows the variation of this ratio with assumed value of lung density. In addition, two centres had a discrepancy greater than 5% in the reference-point measurement.
Each of these centres was followed up to establish the cause of the discrepancy. The causes are summarized below.
, and measured dose at the central point in one of the two dose distributions for 9 of Centre 112. Three separate small errors were subsequently found in the data used for the dose calculation. These all worked in the same direction to produce the measured discrepancy.
Centre 124. The depth-dose data for one particular field size and wedge-angle combination were subsequently found to have been corrupted in the treatment planning computer.
Centre 153. A software fault introduced an error of approximately 1.2% in the output factor used and an additional error of approximately the same magnitude was found in the depth-dose data. When combined with the centre choosing to use their standard lung density (0.5) for the calculation of dose in the second distribution, a net discrepancy in excess of 5% resulted.
Centre 156. This is the same beam for which a 6.1% discrepancy was found for the average reference-point measurement at the three different field sizes. A part of this error (2.8%) was attributed to a high output calibration for the unit on the day of the survey. The centre had been aware of this difference but it was not their standard procedure to adjust the monitor calibration for an isolated measurement at this level. No explanation could be found for the remainder of the difference. For the other treatment unit in this centre the average dose ratio at the reference point was 1.030.
Centre 162. As a consequence of this study it was found that the wedge output factor for this treatment unit could drift relative to the plain field calibration due to the design of the dose monitor unit. This had not been routinely tested before this study had indicated this discrepancy.
Centre 163. In 1988 it became known publicly that there had been a calibration error on a CO-60 unit at the Royal Devon and Exeter Hospital. This resulted in patients receiving doses which were 25% more than had been intended. It has been reported that the discovery of this error resulted from the measurements for this intercomparison (Thwaites 1988) . In view of the consequences of this event, the data from this hospital were never returned for analysis and have not therefore been presented in the preceding sections.
Centre 173. The centre did not supply a reason for this difference but it may be noted that, like centre 153 above, a high value for lung density (0.52) was used.
Centre 181. Incorrectly measured wedge factors were being used at the time of this survey. These were being reviewed by the centre at the time of the intercomparison visit.
Centre 187. A software error in the treatment planning program was found to be the cause of this 8% discrepancy. It was subsequently demonstrated that this fault manifested itself most when long straight outline sections were being input and when the beam was non-perpendicular to the surface. This occurred for a straight-edged phantom. It was subsequently shown that for clinical treatment planning it was highly unlikely that this fault would have occurred. In addition it was noted that, for this phantom study, normal plan checking systems were not applied-these would have been expected to have detected this error.
Centre 190. The large discrepancy in doses for the distribution with the lung inhomogeneity occured because the centre made no correction for the lung. It was the standard clinical practice in this centre not to make this correction and therefore the result represents the error in quoted dose for this centre when such Lreatnients are carried out. It may be presumed that the radiotherapists in this centre take account of the 5.6% discrepancy in central dose for the distribution with a water-equivalent insert.
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Dose calibration
For the planned-dose distributions with the water-equivalent insert, the average ratio of measured-to-calculated dose was 1.008 (with a 95% uncertainty of i0.007 calculated as twice the standard error on the mean). For the reference-point measurements on the same beams, the ratio was 1.005*0.004. This indicates a systematic difference betweewthe measured and the calculated dose. The difference may be due to the phantom, or result from the calibration of the chamber or of the secondary standard chamber itself. When all 161 reference-point measurements are considered, the dose ratio was 1.003*0.002. Although not significant, the difference between the result for the reference point and that for the planned dose distributions suggests that it is the phantom which is causing the higher measured dose. This is because the effect is greater in the planned distribution than at the reference point, which may be expected to be associated with the greater depths of the measurement. If the average dose ratio is used as the standard, only five of the nine centres in table 3 show a difference of 5% or more. No centre showed a dose ratio between 0.950 and 0.958 at the central point.
Nominal beam energy, as stated by the participating centre, was used to select the calibration factor for each measurement. In order to test the consistency of the nominal energies, and the possible resulting errors, individual dose measurements in the phantom were studied to derive an alternative quality-specification parameter.
For the planned dose distributions, the ratio of the measured dose at the two points below the isocentre and the dose at the two points above the isocentre was calculated from the data for beam number one (figure 2). Depth dose data from BIR (1983) were used to correct the measured results to a standard field size (8 x 8 cm2 at the depth of dose maximum). The data were then converted to an infinite FSD. This measured ratio may be used as a parameter to compare beam qualities. The results are shown in table 4 for the four most commonly used energies. Values derived from BIR (1983) are shown for comparison-it can be seen that for CO-60 there is excellent agreement and the standard deviation of the measured results is 0.3%. The measured variation of this quality-specification parameter between 4 and 8 MV is 6.0% (1.5% per MV). The largest range of values was 2.6% at 4 MV, indicating a range of less than + l MV in energy specification. At the two higher energies the range averages 10.6 MV. These uncertainties lead to a maximum uncertainty in CA, and thus in dose, of approximately *0.2%.
Discussion

I . Uncertainties
Factors which contribute to the random uncertainties in the measurements are listed in table 5. The error in dosemeter response has been estimated from data for the strontium check-source measurements. The uncertainty in the temperature correction is equivalent to 10.5 "C. This relatively high value has been assumed because normally there was insufficient time to allow the phantom to equilibrate with its environment. Temperature was measured in the chamber insert but this may not have been an accurate value for the temperature of the air in the ionization chamber. It has been assumed that the error in setting the distance was 2 mm in a distance of 1 m. For cobalt units the dose was calculated from output charts. These are commonly prepared monthly to allow for a decay of 1.1% which corresponds to a random uncertainty of Table 4 . Quality specification parameter ( Z ) equal to the ratio of depth-dose at a depth of 13 cm to that at 7 cm for an 8 x 8 cm2 field size corrected tu infinite FSD.
Nominal
No. of -t0.3%. For megavoltage x-ray units, the uncertainty due to monitor fluctuations estimated by Wittkamper e f al (1987) has been used. These data lead to an overall random uncertainty in the measured data of *0.6% and *0.9% for '20-60 units and megavoltage x-ray units, respectively.
There are systematic errors in the intercomparison dosimetry which may have contributed to the observed differences between the measured and calculated doses. These include the calibration of the secondary standard and the measurement of temperature and pressure. It is estimated that these factors contribute 0.2% to the systematic uncertainty. In addition, there may he a systematic difference due to the phantom material used for this study.
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Reference-point doses
The mean value of the ratio of measured-to-stated doses for the reference-point measurements is close to unity (1.002 for '20-60 and 1.003 for x-rays), showing that no major systematic errors exist. All the average reference-point values lay within +4% of unity, with the exception oftwo beams. One-beam (163)-had an error in calibration that was well understood on investigation and has not been included in the detailed analysis. The second-beam (156)-moves within the 4% level when the daily output calibration factor is taken into account. The standard deviation of thc distribution is 1.5%, part of which is contributed by the experimental uncertainties associated with ihr dosilnaiiy liiieicomjjarisoii dose de:erii;iiiatioii. T h e figu:es can be ccr.pared te those from some other recent intercomparisons for photons (table 61, where standard deviations range from 0.6% for CO-60 in the Dutch study to 3.3% for x-rays in the EORTC measurements. In addition, Svensson (1989) has reported on the IAEA/WHO postal dosimetry service for CO-60 beams-the standard deviation of the observed distribution is 6.7% if results from all countries are included (but excluding from the analysis deviations over 30%, which comprised approximately 1% of the deviations). For European countries participating in the service, the standard deviations for results from individual countries vary from 1.8% to 9%. The UK figures from the present work compare well with these other recent results. Some of the above (EORTC, for example) are linked to clinical trials and only include the participating centres, for which lower variations might have been expected. However, such international comparisons include centres which may follow a number of different dosimetry protocols. In the UK there is a standard dosimetry system (involving NPL), a single design of secondary standard transfer instrument/designated chamber for photons (NE 2561) and tightly written protocols. This gives little flexibility and thus less scope for error in selection of correction factors etc, in order to ensure consistency.
A criticism that has been made of the 1983 U K protocol (HPA 1983) concerns the continued use of MV as a quality-specifying factor. The more recent protocol (IPSM 19904 has changed this approach. However it can be seen from the quality analysis in section 3.4 that the MV approach introduces only small additional uncertainties into the dosimetry. This is due to the fact that nominal MV, as generally used in UK centres, reflects a quality specification based on practical depth dose curves, as do other recommended quality indices. The nominal MV taken for a given beam has generally been based on a comparison between the depth dose data for that beam and the data in BIR (1983) or its forerunners.
Three areas, which could benefit from increased attention, have been highlighted in these measurements.
(i) Definitive beam calibrations should have independent checks. IPSM advice has been formulated on this (IPSM 1990b) .
(ii) Some field-size variations are apparent, pointing to a need for particular care in determining the dose in small field sizes.
(iii) Significant variations were noted in some centres between beams, pointing to a need for careful implementation of dosimetry protocols and practices in all beams available in a particular centre.
Finally it may be noted that EORTC and the RPC (USA) both specify an acceptance level for reference-point measurements to be within *3% of stated values, for compliance with clinical trial requirements. In this study, 157 out of 162 (97%) of MVphoton beams in the UK lay within that level.
Planned dose distributions
In this part of the study, with more factors contributing to the uncertainty, the standard deviation of the distributions is seen to rise to 2.7% (homogeneous phantom) and 3.5%
(lung inhomogeneity present), with a larger number of discrepancies greater than 5%, as discussed in section 3.3. It is difficult to compare the present study, deliberately based on a simple geometric phantom, to other intercomparisons in planned multi-beam situations, as the few that have been reported are in anatomical phantoms and have considered a variety of sites. However, it is appropriate to compare results at the central point in the present work to those at target centre points in other studies, table 7 shows this comparison, The results from this study were similar to most of the other investigations. It may be noted that the Dutch study showed a particularly low standard deviation.
Some of the intercomparisons, which used anatomical phantoms to simulate the clinical situation, reported deviations due to clinical or 'patient' factors. The present approach is to separate physical aspects deliberately by using a non-anatomical phantom which was simple in shape and simple to set up, but complex enough to require correction factors which contributed to the uncertainties. It is feir that Cui1 diuical intercomparisons may best be carried out in combination with particular clinical trials and specific sites, by carrying out related quality audits of techniques, prescription, planning, etc. This is designed to separate the assessment of underlying physical uncertainties, common to all sites, from the clinical aspects. In terms of trial criteria, or wider recommendations on accuracy, discrepancies of 5% or more were observed in 15% of the centres, with 89% of the measured distributions being within 5% of unity. It should be emphasized that the variations observed include no contributions from patient-related factors or from uncertainties associated with day-to-day variations present throughout a typical treatment couse. The encouraging result of this part of the study is that discussion with those centres, in general, produced explanations for the discrepancies, leading to an improvement of practice. Particular aspects which would benefit from increased attention include: (i) the requirement to establish comprehensive QA programmes on all aspects of procedures, with built-in second checking where necessary; (ii) the precision and stability of data for beam modifiers, particularly wedges; (iii) the need for quality control of data stored on computer; (iv) the potential limitations of treatment planning systems; (v) the applicability of the inhomogeneity corrections used; (vi) the need for vigilance in all aspects of the radiotherapy process, as a number of small errors can cumulatively give rise to significant discrepancies.
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Conclusions
The U K radiotherapy dosimetry intercomparison has proved effective. It has provided quantitative information on the consistency of radiotherapy dosimetry. It has improved the quality of dosimetry by highlighting some problems, leading to improvements in practice in some centres. I t has provided an independent check (audit) of dosimetry procedures, giving support to local personnel and methods. Such an intercomparison forms an essential part of wider radiotherapy audit processes.
The practical situation in the U K has been. shown to be generally good for MV photon beams, but the study underlines the fact that there is no room for complacency in radiotherapy dosimetry. The work points to other possible investigations, in particular the need for a similar assessment of the consistency of UK electron beam dosimetry. Good clinical trials and the confident transfer of clinical experience between centres can only be based on continuing confidence in consistent dosimetry, not only within any given country, but also across national boundaries. Thus the intercomparison must be seen in the context of other national and internatioal intercomparisons and must be linked to these studies to add to the growing body of information in this area. In addition, other studies have shown that there are improvements in time with repeated intercomparisons, due in part to the effect of the intercomparisons themselves, and that on-going audit is to be recommended. However, the present study indicates that limitations on time and resources must be overcome for regular intercomparisons to be effective, based on careful organization and consistency in personnel, equipment and methods.
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